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Nanoparticles are regarded as promising carriers for targeted drug delivery and imaging probes. A fundamental
understanding of the dynamics of polymeric nanoparticle targeting to receptor-coated vascular surfaces is therefore
of great importance to enhance the design of nanoparticles toward improving binding ability. Although the effects
of particle size and shear flow on the binding of nanoparticles to a vessel wall have been studied at the particulate
level, a computational model to investigate the details of the binding process at the molecular level has not been
developed. In this research, dissipative particle dynamics simulations are used to study nanoparticles with diameters
of several nanometers binding to receptors on vascular surfaces under shear flow. Interestingly, shear flow velocities
ranging from 0 to 2000 s−1 had no effect on the attachment process of nanoparticles very close to the capillary
wall. Increased binding energy between the ligands and wall caused a corresponding linear increase in bonding
ability. Our simulations also indicated that larger nanoparticles and those of rod shape with a higher aspect ratio
have better binding ability than those of smaller size or rounder shape.
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Nanoparticulate systems have been widely used for drug
and gene delivery, imaging, and photodynamic therapy
[1–12]. A typical nanoparticulate system consists of a
nanoplatform, such as liposomes, polymeric micelles,
quantum dots, nanoshells, or dendrimers, coated with
ligands like hydrophobic drugs, DNA, or imaging agent.
Ligands direct the nanoplatforms to specific locations
and help to improve their bioavailability during circula-
tion in a biological system [2, 3, 7–10, 13, 14]. Two main
methods are used to transport ligand-coated nanoparti-
cles (NPs) to diseased sites: passive and active targeting.
In passive targeting, the accumulation of NPs is
achieved by the enhanced permeability and retention
effect [3, 7, 10, 15, 16] because the leaky vasculature
and low lymphatic drainage prolong the residence time of
NPs in the tumor. Conversely, active targeting is mediated* Correspondence: beipeng@uestc.edu.cn
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in any medium, provided the original work is pby specific interactions between ligands that are connected
via flexible spring tethers and receptors that are overex-
pressed at the pathological site. The highly concentrated
receptors around pathological sites are preferred for ligand
interaction because they can enhance NP internalization
and retention [3, 7, 10, 15, 16].
Understanding the effects of NP size, hydrodynamic
force, and multivalent interactions with a targeted bio-
surface on the mechanisms of a targeted delivery process
is essential to aid the design and fabrication of NP sys-
tems [15]. Experimental techniques, such as fluorescence
spectroscopy combined with microfluidics [17] and sur-
face plasmon resonance [18], have been developed to in-
vestigate the ligand–receptor binding kinetics in vivo.
The acquired experimental data indicate that the process
of NP binding to a targeted surface is a synergic result
of many factors, including the shape and diffusion of
NPs, the flow effects [17, 19], as well as binding and in-
ternalization kinetics [20]. However, exploring this
phenomenon experimentally is a very time-consuming
task because of the small size of NPs and the dynamic
nature of the transportation–deposition process; moreover,Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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process is very fast.
Therefore, theoretical modeling and numerical simula-
tion have been performed to study the margination and
adhesion processes of NPs in a fluid. For instance, Liu
et al. [21] investigated the shape-dependent adhesion
kinetics of non-spherical NPs through theoretical model-
ing. The influences of NP shape, ligand density, and shear
rate on bonding ability under Brownian dynamics were
systematically studied. They also investigated the distribu-
tion of NPs with different shapes and sizes in a mimetic
branched blood vessel and found that NPs with smaller
size and rod shape have better bonding ability [19].
Dissipative particle dynamics (DPD) simulations can
precisely model hydrodynamic interactions at a mesoscopic
scale with acceptable time scales [22, 23], which can over-
come the limitations of molecular dynamics simulations
[24, 25] to predict complex hydrodynamics with much
higher efficiency. Although DPD was first introduced to
simulate the dynamics of fluids [26–28], it has been suc-
cessfully used to reproduce hydrodynamic forces [27],
explore the phase behavior of lipid molecules [29], and
study the interactions of biomembranes and NPs [30–33].
For example, Filipovic et al. [34] used DPD to simulate the
motions of circular and elliptical particles in 2D shear flow
and compared their results with those obtained from finite
element (FE) calculations to validate the ability of the DPD
method to model the motion of micro/nanoparticles at the
mesoscale. They also combined the multiscale mesoscopic
FE bridging procedure with DPD and the lattice
Boltzmann method to model the motion of circular and
elliptical particles in 2D laminar flow [35]. This approachFig. 1 Coarse-grained model of a spherical nanoparticle (NP) and capillary
covered with receptors (receptor effect was included in the potential but n
of each ligand; the pink beads represent the head of each ligand (hydroph
(hydrophilic beads) that are permanently attached to the NP. The structure
for clarityproved to be an effective way to model the motion of NPs
in drug delivery systems. Meanwhile, Ding et al. [36] stud-
ied the effects of the coating ligands on the cellular uptake
of NPs and found that the strength of the receptor–ligand
interaction along with the density, length, and rigidity of
the ligand can markedly affect the final equilibrium in
receptor-mediated endocytosis.
Despite these exciting advances, theoretical modeling
using approaches such as Brownian adhesive dynamics
can provide some insights into adsorption kinetics and
the dynamics of adsorbed NPs but lacks specific details
about the binding process [37, 38]. This paper presents
the details of dynamic transportation and adhesion of
NPs to a vascular wall under shear flow determined
using DPD simulations. Parameters such as bonding
time and the mean-square displacement of NPs are con-
sidered. Results obtained for spherical NPs with different
binding forces and diameters and for NPs with different
shapes or aspect ratios but the same volume are com-
pared to assess the influence of such parameters on the
binding of NPs to a vascular wall.
Methods
Coarse-Grained (CG) Model: DPD Simulation
To achieve targeted drug delivery, NPs are usually
coated with polymers that specifically bind to a particu-
lar type of receptor on the vessel cell surface [37, 38]. It
is computationally expensive to model the transportation
and adhesion processes using an atomistic molecular dy-
namics simulation. However, the coarse-grained (CG)
method guarantees that the general trend of the simula-
tion will be determined without entirely erasing thesurface. The NP is coated with ligands, and the vascular surface is
ot explicitly modeled). The cyan beads represent the functional ends
obic beads); and the green beads represent the tail of each ligand
of the chains is magnified in the inset. Solvent molecules are omitted
Fig. 2 Bonding time for the attachment of NPs with strong binding
strength. Bonding time required from the beginning of the
simulation to firmly bond 2-nm NPs to the wall under a shear flow
of 1000 s−1 when 13 < Δa < 25
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used to represent the components within the simulation
system. The ligands on each NP were modeled as a
chain of ten coarse-grain beads, namely, three hydropho-
bic beads and seven hydrophilic beads connected linearly
to represent the polar head groups. As shown in Fig. 1,
chains were uniformly distributed on the surface of a
spherical NP. A harmonic potential was used to model
the diblock copolymer chain, and the spring constant
was set to 100 (reduced DPD units).
The size of the simulation box in our work was 22rc ×
22rc × 22rc (rc is interaction length) with periodic
boundary conditions in the x and y directions. The vas-
cular surface was simplified as a fixed wall and placed at
the boundary of the system consisting of fixed CG beads
during the simulation. The wall was impenetrable with a
“no slip” boundary condition where both the normal and
tangential components of the particle momentum were
inverted [40]. During the whole process, the wall parti-
cles did not move, acting as the location of the receptor
that could interact with the ligands on the NPs. NPs
with a diameter of 2 nm were also modeled by rigid
beads placed in the middle of the box and filling the rest
of the space with 27,783 explicit fluid particles [41]. The
number densities ρ of the vascular wall and fluids were
set as 3, as suggested elsewhere [42].
Interaction Forces and Units in DPD Simulations
The interaction forces between different beads in the
DPD formulation include a conservative force f C, a
bead-spring force of the bonded monomers f S, a dissipa-
tive force f D, and a random force f R [43]:
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where aij is the repulsion factor, rij and vij are the re-
spective distance and velocity vectors of particle i withTable 1 Repulsion factors between elements used in DPD
simulations
Repulsion factor
Element FE HL TL NP VS WM
FE 25 45 25 25 5 25
HL 25 45 45 45 45
TL 25 25 25 25
NP 25 25 25
VS 25 25
WM 25respect to particle j, rc, and rs are the respective cutoff
distances for conservative and bead-spring forces, K, γ,
and σ denote the spring constant, friction coefficient, and
noise amplitude, respectively, ωD and ωR are the weight
functions (ωD = (ωR)2 = (rc − rij)
2), ɛij is the Gaussian ran-
dom number, and Δt is the simulation time step.
The random noise strength is expressed as a function
of the dissipation strength and temperature T via the
fluctuation–dissipation relation [28],
σ ij
2 ¼ 2γijkbT ð2Þ
where σij and γij are the random noise strength and dis-
sipation strength between beads i and j, respectively. We
carried out the simulations using a frictional coefficient
γ of 3.Fig. 3 Mean and standard deviations of bonding time for NPs
of different sizes. Data for NP diameters of 2, 4, and 6 nm
are presented
Fig. 4 Mean and standard deviations of bonding time for NPs of
different shapes. Shapes include spherical NPs and nanorods with γ
of 5, 10, and 15, Δa = 20
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described by the repulsion factor aii = 25kbT/rc to guaran-
tee the compressibility of water at room temperature.
Interaction factors between hydrophobic and hydrophilic
beads were set to 45, while the others were set to 25 [44].
The repulsion factors between different elements used in
the DPD simulation are listed in Table 1, where FE, HL,
TL, VS, and WM denote the functional end of the ligand,
the head of the ligand, the tail of the ligand, the vascular
surface, and a water molecule, respectively.
To implement DPD simulation, rc, the bead mass m, and
the thermostat temperature kbT were set as unit elements
[43, 45, 46]. All simulations were performed in the NVE
ensemble with constant particle number N, simulation box
volume V, and energy E. The velocity Verlet algorithm was
used to integrate with a relatively small time step of
Δt = 0.02τ, and each simulation was run for 4 × 105 steps.
Simplified Shear Rate
To apply shear flow in the flow region, we employed the





þ yzvδi; ð3ÞFig. 5 Bonding process of a spherical NP. NP (2 nm) under shear flow of 1
molecules are omitted for claritydpi;v
dt
¼ Fi;v− y• pz;vδi; ð4Þ
where ri,v, pi,v, and mv are the position vector, peculiar
momentum, and mass of the vth bead, respectively, y• is
the shear rate, and δi is the unit vector in the x direction.
This approach allows us to impose a linear velocity pro-
file in the x direction with a constant gradient in the z
direction.
Statistical Analysis
We examined the significance of the data presented in
Figs. 2, 3, and 4 below. All P values were <0.05, so these
data are significant at 0.05 level, indicating that it is
highly unlikely that these results would be observed
under the null hypothesis, and bonding times for differ-
ent x values are significantly different. Therefore, even
though the error bars in these figures look wide, the re-
sults are reasonable.
Results and Discussion
The bonding processes of NPs under different shear
flows were simulated with the developed CG model. A
typical NP bonding process is shown in Fig. 5. As illus-
trated in Fig. 5a, the functional ends of an NP sense the
attraction force from the vascular surface, and the li-
gands start to move toward the wall surface. Then, the
NP is attracted to the wall until it is firmly attached to
it, as shown in Fig. 5b, c.
Effect of Binding Energy on Ligand–Receptor
Binding Kinetics
Experimental results have shown that binding energies
from 5 to 35 kbT strongly influence ligand–receptor
binding kinetics [49]. In DPD simulation, the binding
factor Δa is defined as the difference between the lig-
and–receptor repulsion factor and the receptor–solvent
repulsion factor. To simulate different attractive forces
between ligands and the vascular surface, we varied
the ligand–receptor repulsion factor while keeping the
receptor–solvent repulsion factor constant. Here, Δa = 5
indicates weak binding and the ligand–receptor repulsion000 s−1 when Δa = 20. a t = 1800. b t = 1850. c t = 1900. Solvent
Fig. 7 MSD as a function of bonding time. The y-axis is the
MSD of the NP, and the x-axis is the corresponding time. Shear
rates of 500, 1000, 1500, and 2000 s−1 with Δa = 13 for 2-nm
NPs are considered
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while Δa = 25 indicates strong binding and the ligand–
receptor repulsion factor is close to zero [44].
For relatively weak binding strength (5 < Δa < 11),
NPs mostly lingered in the middle of the flow domain
and only a fraction of them established a stable contact
with the receptor surface. For relatively strong binding
strength (13 < Δa < 25), bonding readily occurred and
the binding time (from the beginning of the simulation
to stable attachment) was measured. Figure 6 reveals
that the probability of attachment initially increased
linearly from about 10 to 30 % when 5 < Δa < 9, and
then increased abruptly to nearly 100 % when Δa = 11.
Figure 2 depicts ten different simulations run using vari-
ous binding strengths. The mean bonding time de-
creased almost linearly as Δa increased. The standard
deviation of bonding time for each Δa also decreased as
Δa increased. Therefore, NPs with a large bonding force
have a higher probability of bonding and take less time
to bond than those with a small bonding force. These re-
sults agree well with a previous report [44], which stated
that when Δa ≈ 12 or larger, any initial contact between
ligands and a vascular surface leads to stable attachment.
Effect of Shear Flow on the Binding Process
The physiological range of shear rate in blood flow is ap-
proximately 40–2000 s−1, including flow within postca-
pillary venules, large arteries, and arterioles/capillaries
[50]. In this paper, simulations were carried out for shear
rates ranging from 0 to 2000 s−1 to study the NP bond-
ing process under different shear flow conditions. The
mean-square displacement (MSD) of 2-nm NPs under
different shear rates was determined, and the results are
shown in Fig. 7.
To simplify the analysis, we set Δa = 13, which meant
that the NPs would readily attach to the wall and theFig. 8 Effect of shear flow on bonding time and MSD. For 2-nm NPs
with Δa = 13
Fig. 6 Probability of attachment of NPs with weak binding strength.
NP (2 nm) under shear flow of 1000 s−1 when 5 < Δa < 11
Fig. 9 Effects of NP size on the binding process. Bonding times of
NPs with diameters of 2, 4, and 6 nm when Δa = 20; data are sorted
in ascending order
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the trajectory of NPs can be traced from their MSD. Ini-
tially, an NP moves randomly in the middle of the box
under the influence of shear force and Brownian motion,
and thus, the curve rises and falls at the outset. When
the NP moves near the wall, it is attracted by the recep-
tors, so it progresses to the wall and is bound to it, at
which point the curve reaches the maximum MSD. After
binding, the NP can still move because of the drive vel-
ocity [44] originating from the Brownian movement.
The chains of each NP are long enough to allow reason-
able vibration of the NP. Therefore, the curve subse-
quently fluctuates around the ultimate MSD.
Higher shear rate is reported to result in lower bond-
ing possibility for NPs when the NP diameter is largerFig. 10 Coarse-grained model of a nanorod and capillary surface. The nano
γ = 3. Solvent molecules are not shown for claritythan 100 nm [51]. However, we found that the bonding
efficiency (time needed for the NPs to reach equilibrium)
did not decrease with increasing shear rate, as seen in
Fig. 7. The bonding situation may be different for NPs
with a diameter of 2 nm in fluid at a position 20 nm
above the capillary wall, so we compared the bonding
time and ultimate MSD of NPs for shear rates ranging
from 0 to 2000 s−1, as shown in Fig. 8. With increasing
shear rate, the bonding time and ultimate MSD do not
decrease accordingly. Instead, the spots appear randomly
in relation to shear rate, which means that the shear rate
has no effect on the bonding process in a certain area.
Even when the shear rate was set to 0 s−1, the bonding
time was still longer than that in most cases with shear
rate. This is because Brownian force outweighs the drag
force and is the dominant force for NPs larger than 100
nm [51], a phenomenon that is even more obvious for
smaller NPs. This is the reason for the heterogeneous
binding time and MSD in Fig. 8. As a result, for NPs
with a diameter of 2 nm, the bonding probability is not
influenced by shear rate. NPs will firmly bond to the wall
once in contact with it, and thus, bonding condition is
dominated by diffusive process and independent of shear
flow. We also simulated the behavior of NPs with diame-
ters of 4 and 6 nm under the same conditions and ob-
tained equivalent results.
Effect of NP Size on the Binding Process
The Brownian force FB∝R
1
2 for roundnanoparticle in fluid
 
will increase with the size of the NPs. Therefore, NPs with
diameters of 4 and 6 nm were also simulated to study how
NP size affects its bonding process. The size limitation of
the simulation box meant that 6 nm was the largest size of
NP we could investigate here. The bonding times of NPs
with diameters of 2, 4, and 6 nm are illustrated in Fig. 9.rod has the same volume and ligands as the 2-nm spherical NP, where
Fig. 12 Effects of NP shape on the binding process. The bonding
times of a spherical NP and nanorods with γ of 5, 10, and 15 were
measured. The NP volume was kept constant; data are sorted in
ascending order
Fig. 11 Bonding process of a nanorod. Δa = 20 and γ = 3. a t = 1500. b t = 1550. c t = 1600. Solvent molecules are omitted for clarity
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ger NPs.
To allow quantitative analysis, the mean and standard
deviations of bonding time for NPs of different sizes are
presented in Fig. 3. Figure 3 reveals that the average
bonding times are shorter and the standard deviations
smaller for larger NPs. In our simulation, Brownian
force is the determinative force, indicating that the mo-
tion of small particles in fluids is controlled by random
collisions with surrounding fluid molecules. The random
collision of NPs of smaller size is less likely to be bal-
anced than that of larger NPs. If the unbalanced force is
not in the direction of the wall, which is more likely to
happen than the force being in the direction of the wall,
the NP is less likely to be attracted to the wall and its
bonding time will be prolonged. The track of a smaller
NP is more disordered than that of a larger NP because
of the unbalanced random force, which results in a lar-
ger standard deviation. Thus, the simulation results
demonstrate that a bigger NP has higher bonding ability
than a smaller one.
Effect of NP Shape on the Binding Process
Both simulation and experimental results show that
shape strongly affects pharmacokinetics and pharmaco-
dynamics [52]. Different shapes cause contact areas, ran-
dom forces of Brownian motion, and drag forces
induced by shear flow to vary. Therefore, rod-shaped
NPs (nanorods) were investigated in addition to spher-
ical NPs to study the effect of NP geometry on the par-
ticle bonding process [38]. Nanorods with aspect ratios
(γ; ratio of long axis to short axis) [51] of 5, 10, and 15
were considered. Nanorods with γ = 3 is shown in
Fig. 10. The volume of the nanorods used was the same
as that of the 2-nm NPs to ensure the same drug load
capacity.
Figure 11 illustrates the bonding process of a nanorod.
In Fig. 11a, the ligands on the end of the nanorod start
to sense the attraction force from the vascular surface.
Then, the ligands on the side of the nanorod are grad-
ually absorbed by the wall until they are firmly attached
to it, as depicted in Fig. 11b, c.Figure 12 compares bonding times for NPs of different
shapes. Bonding efficiency was higher for nanorods than
spherical NPs, and increased with γ. Figure 4 reveals that
the average bonding time and standard deviation were
smaller for nanorods than spherical NPs. This is because
of the tumbling motion and the larger contact area of
the nanorods compared with the spherical NPs [38]. The
contact area of a spherical NP is irrelevant to its orienta-
tion, and the binding area remains constant within inter-
acting distance. Conversely, for nanorods, the contact
area depends on orientation, and there is a higher
chance to initiate contact with the wall because of its
longer length compared with spherical NPs. Both the
mean and standard deviations of bonding time decrease
with increasing γ because NPs with a larger γ are thin-
ner and longer, so the ligands on the end of the nanorod
have a higher chance of interacting with the wall. These
results are consistent with the finding that the strength
of adhesion increases with γ [53], and thus, the bonding
time decreases.
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We used DPD simulations to study the dynamics of po-
lymerized NP binding with a vascular surface. We de-
scribed in detail how the shear rate, bonding energy,
size, and shape of an NP affect its bonding ability. The
results indicate that the bonding ability increases linearly
with bonding energy. Interestingly, the shear rate does
not influence the bonding process of NPs with a diam-
eter of 2–6 nm in a liquid environment 20 nm above the
capillary wall. Compared with small spherical NPs, those
with larger diameter or rod shape will move in a more
orderly manner and require less time to reach the sur-
face of the capillary wall, which means that they have
better bonding efficiency. Additionally, the bonding abil-
ity of nanorods increased with γ. Our results provide
some useful theoretical bases for designing NPs, which
may aid in the development of new types of NPs with ad-
vantageous functionalities for biomedicine applications.
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